Search results
Studies reveal cell-by-cell changes caused when pig hearts and kidneys are transplanted into humans
Medical Xpress· 3 hours agoLed by researchers at NYU Grossman School of Medicine and the Broad Institute of MIT and Harvard,...
Hansa Biopharma to present data at 2024 American Transplant Congress annual meeting
NBC 17 Raleigh· 13 hours agoImlifidase has conditional marketing approval in Europe under the trade name IDEFIRIX® for the desensitization treatment of highly sensitized adult kidney transplant ...
‘She’s my hero’: Wife donates kidney to save husband’s life after he was diagnosed with rare disease
WNDU 16 South Bend· 2 days agoA woman in Nashville donated one of her kidneys to her husband after he was diagnosed with a rare disease. Amy Bredfeldt said their journey began in 2022 when her husband, ...
The first man to receive a kidney transplant from a genetically modified pig has died
NPR· 7 days agoWILLIAMS: We do not think that the transplant contributed to his unfortunate passing. No, we don't. STEIN: Williams says doctors learned a lot from Slayman's experience, like ...
First human to receive transplanted pig kidney dies
Reuters· 7 days agoA man with end-stage renal disease who earlier this year became the first human to receive a new kidney from a genetically modified pig has died,...
Q1 2024 OncoCyte Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 days agoOur own research is breaking new ground in transplant. We see an opportunity for OncoCyte’s technology to improve transplant rejection
Xenotransplant Responses, Interactions Unraveled With Multiomic Analyses
GenomeWeb News· 4 days agoThe two pig heart xenografts were transplanted "with the primary aim of assessing the presence of hyperacute antibody-mediated rejection (AbMR) and sustained ...
OncoCyte Corp (OCX) Q1 2024 Earnings Call Transcript Highlights:
Guru Focus· 6 days agoThe company has successfully initiated early commercialization efforts and is poised for unprecedented growth over the next 12 to 18 months, driven by multiple milestones. OncoCyte Corp's technology ...
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in...
WTRF Wheeling· 6 hours agoDURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies to transform the treatment of serious and life-threatening conditions ...